CRYSTALLINE (1R,4R)-6'-FLUORO-N,N-DIMETHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,B]INDOL]-4-AMINE

The present invention relates to crystalline forms A, B, C, D, E and F of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro [cyclohexane-1-1'-pyrano[3,4,b]indo]-4-amine. The present invention also relates to pharmaceutical compositions and medicaments comprising these modifications, the use of these modifications, for example in compositions for the treatment of pain in a subject with a pain disorder, as well as to process for the enrichment of them..

Medienart:

Patent

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Europäisches Patentamt - (2020) vom: 15. Dez. Zur Gesamtaufnahme - year:2020

Sprache:

Englisch

Beteiligte Personen:

GRUSS MICHAEL [VerfasserIn]
PRUHS STEFAN [VerfasserIn]
KLUGE STEFAN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2020-12-15, Last update posted on www.tib.eu: 2023-07-24, Last updated: 2023-07-28

Patentnummer:

CA2841032

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA008315620